Does anyone else find it disturbing that the FDA associate commissioner used the term "manufacture" when describing this company's activities?
"Allowing the firm to continue to manufacture would present a danger to public health by increasing the risk of communicable disease transmission," says Margaret O'K. Glavin, associate commissioner of the FDA's office of regulatory affairs.